Company profile for AIkido Pharm

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

AIkido Pharma Inc. is a biotechnology development company working to develop a diverse portfolio of early and mid-stage small-molecule anti-cancer therapeutics. The AIkido Pharma Inc. platform contains patented technology from leading universities and researchers and we seek to develop our innovative drugs through strong partnership with world renowned institutions, such as The University of Texas and Wake Forest University. O...
AIkido Pharma Inc. is a biotechnology development company working to develop a diverse portfolio of early and mid-stage small-molecule anti-cancer therapeutics. The AIkido Pharma Inc. platform contains patented technology from leading universities and researchers and we seek to develop our innovative drugs through strong partnership with world renowned institutions, such as The University of Texas and Wake Forest University. Our diverse pipeline of therapeutics includes therapies for prostate, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL). Our prostate and pancreatic treatment has shown positive precl

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
One Rockefeller Plaza 11th Floor New York, NY 10020
Telephone
Telephone
(212) 745-1374
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

34th NZW-Hamburg

Not Confirmed

envelop Contact Supplier

34th NZW-Hamburg

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
AIkido Share Repurchase Continues
AIkido Share Repurchase Continues

06 Oct 2022

// PRNEWSWIRE

https://www.prnewswire.com/news-releases/aikido-share-repurchase-continues-301642680.html

PRNEWSWIRE
06 Oct 2022
Share Repurchase Program Continues
Share Repurchase Program Continues

04 Oct 2022

// PRNEWSWIRE

https://www.prnewswire.com/news-releases/share-repurchase-program-continues-301640067.html

PRNEWSWIRE
04 Oct 2022
AIkido Announces Reverse Stock Split
AIkido Announces Reverse Stock Split

03 Jun 2022

// PRNEWSWIRE

https://www.prnewswire.com/news-releases/aikido-announces-reverse-stock-split-301561171.html

PRNEWSWIRE
03 Jun 2022

https://www.prnewswire.com/news-releases/aikido-pharma-announces-company-commitment-to-board-diversity-301550922.html

PRNEWSWIRE
19 May 2022

http://www.pharmabiz.com/NewsDetails.aspx?aid=147376&sid=2

PHARMABIZ
14 Mar 2022

https://www.prnewswire.com/news-releases/cedars-sinai-medical-center-and-aikido-pharma-inc-to-codevelop-novel-immuno-oncology-cancer-treatment-301500752.html

PRNEWSWIRE
11 Mar 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty